Search
for

    Sort by

    Research

    990-1000 / 1000+ results

      research Comorbidities in Dermatology

      9 citations , November 2018 in “Dermatologic Clinics”
      This review highlights recent literature on comorbidities in dermatologic diseases, emphasizing the need for further research into connections between atopic dermatitis and pancreatic cancer, and pemphigus diseases and COPD, but it reports no new clinical results.

      research Adult Onset Still Disease

      May 2021 in “Medicina internă”
      This case report highlights a 31-year-old male with Adult Onset Still Disease, whose symptoms, including high fever, responded only to pulse-therapy with Methylprednisolone after failing to improve with usual treatments.
      Pre-Clinical In-Vitro Assays for High Throughput Screening of Drug Candidates for Protection and Restoration of Immune Privilege in Alopecia Areata

      research 1419 Pre-clinical in-vitro assays for high throughput screening of drug candidates for protection and restoration of immune privilege in alopecia areata

      April 2023 in “Journal of Investigative Dermatology”
      This research developed new in vitro models for high-throughput screening of drugs that could protect or restore immune privilege in hair follicles, finding that Tofacitinib was effective in preventing inflammation-related marker upregulation, while Tacrolimus and αMSH worked specifically in outer root sheath keratinocytes.

      research 69-Year-Old Man With Dysuria and Right Lower Abdominal Pain

      June 2022 in “Mayo Clinic Proceedings”
      This case report describes a 69-year-old man diagnosed with stage 3 acute kidney injury secondary to new IgG kappa light chain multiple myeloma, where treatment with bortezomib-based therapy showed potential for kidney function salvage.
      COVID-19 and Skin: A New Chapter in Dermatology

      research COVID-19 and Skin (A New Chapter in Dermatology)

      October 2021 in “Nepal journal of dermatology, venereology & leprology”
      This article discusses the dermatological challenges posed by COVID-19, including skin conditions linked to infection and protective equipment use, and reports no new clinical findings.

      research Cutaneous lupus erythematosus induced by tislelizumab

      1 citations , April 2024 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft”
      In this case report, the authors concluded that cutaneous lupus erythematosus was induced by the PD-1 inhibitor tislelizumab during treatment for metastatic lung adenocarcinoma, despite initial remission and treatment adjustments.
      Tacrolimus in Dermatology

      research Tacrolimus in Dermatology

      35 citations , August 2001 in “Journal of Cutaneous Medicine and Surgery”
      This paper reviews the use of tacrolimus for various conditions, noting its effectiveness in treating certain skin disorders but highlighting that some findings remain anecdotal due to limited case numbers.